期刊文献+

Purification and characterization of Moschatin, a novel type Ⅰ ribosomeinactivating protein from the mature seeds of pumpkin (Cucurbita moschata), and preparation of its immunotoxin against human melanoma cells 被引量:9

Purification and characterization of Moschatin, a novel type Ⅰ ribosomeinactivating protein from the mature seeds of pumpkin (Cucurbita moschata), and preparation of its immunotoxin against human melanoma cells
暂未订购
导出
摘要 A novel ribosome-inactivating protein designated Moschatin from the mature seeds of pumpkin (Cucurbita moschata) has been successively purified to homogeneity, using ammonium sulfate precipitation, CM-cellulose 52 column chromatography, Blue Sepharose CL-6B Affinity column chromatography and FPLC size-exclusion column chromatography. Moschatin is a type 1 RIP with a pI of 9.4 and molecular weight of~29 kD. It is a rRNA N-glycosidase and potently blocked the protein synthesis in the rabbit reticulocyte lysate with a IC_(50) of 0.26 nM. Using the anti-human melanoma McAb Ng76, a novel immunotoxin Moschatin-Ng76 was prepared successfully and it efficiently inhibited the growth of targeted melanoma cells M_(21) with a IC_(50) of 0.04 nM, 1500 times lower than that of free Moschatin. The results implied that Moschatin could be used as a new potential anticancer agent.
出处 《Cell Research》 SCIE CAS CSCD 2003年第5期369-374,共6页 细胞研究(英文版)
关键词 ribosome-inactivating protein (RIP) Moschatin immunotoxin. 南瓜 种子 核糖体 免疫毒素 黑素瘤
  • 相关文献

参考文献1

二级参考文献35

  • 1[1]Mathers CD, Sadana R, Salomon JA, Murray C J, Lopez AD. Healthy life expectancy in 191 countries, 1999.Lancet 2001; 357(9269):685-91.
  • 2[2]Clark S. Experts predict global devastation due to HIV/AIDS. Lancet 2002; 360(9327):45.
  • 3[3]Stover J, Walker N, Garnett GP, et al. Can we reverse the HIV/AIDS pandemic with an expanded response? Lancet 2002; 360(9326):73-7.
  • 4[4]Buve A, Bishikwabo-Nsarhaza K, Mutangadura G. The spread and effect of HIV-1 infection in sub-Saharan Africa. Lancet 2002; 359(9322):2011-7.
  • 5[5]Douek DC, Brenchley JM, Betts MR, et al. HIV preferentially infects HIV-specific CD4+ T cells. Nature 2002;417(6884):95-8.
  • 6[6]Palella F J, Jr., Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338(13):853-60.
  • 7[7]Stebbing J, Gazzard B. Resistance in HIV. Journal of HIV therapy 2002; 12(4):181-5.
  • 8[8]Gerrish P. The rhythm of microbial adaptation. Nature 2001; 413(6853):299-302.
  • 9[9]Stebbing J, Portsmouth S, Gazzard B. Virus-host interactions. Journal of the Royal College of Obstetricians and Gynaecologists 2002; 9(3):152-9.
  • 10[10]Walker BD, Korber BT. Immune control of HIV: the obstacles of HLA and viral diversity. Nat Immunol 2001;2(6):473-5.

共引文献4

同被引文献37

引证文献9

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部